BDRP Past President Appointed to White House Transition Team


As the White House prepares the hand-off from one administration to the next, one member of the Society for Birth Defects Research and Prevention (BDRP) will have an influential role when it comes to the U.S. Health and Human Services. José F. Cordero, MD, MPH, a faculty member of the University of Georgia and BDRP Past President (1996 – 1997) has been appointed to the President-Elect Biden transition team.

Dr. Cordero is one of 600 transition appointees, 80 of which are university professors, from around the country lending their expertise to various agency review teams. Dr. Cordero will serve on the U.S. Health and Human Services advisory team. To read more about other college professors influencing the White House transition, read this article in Forbes.

Dr. Cordero is a Patel Distinguished Professor of Public Health and Head of the Department of Epidemiology and Biostatistics at the University of Georgia College of Public Health.  He also serves as the Executive Director of the Puerto Rico Brain Trust for Tropical Diseases Research and Prevention, a group focused on developing tests, vaccines, and prevention strategies for diseases like Zika, Dengue and others. He served for 27 years in the US Public Health Service at the Centers for Disease Control and Prevention (CDC).   During his years at CDC he was appointed Assistant Surgeon General of the Public Health Service and held positions focused on improving the health of mothers, children and adults in programs such as, immunizations, birth defects and disabilities. In 1994, he was appointed Deputy Director of the National Immunization Program and in 2001 he was selected as the founding Director of the National Center on Birth Defects and Developmental Disabilities.

In addition to serving as BDRP Past President, Dr. Cordero has also served on the CME Program Committee and as a BDRP Mentor.  

Recent Stories
CERSI-FDA Workshop on Prenatal Somatic Cell Gene Therapies, October 26, 2021

Call for Nominations: F. Clarke Fraser New Investigator Award, Patricia Rodier Mid-Career Award, and Edward W. Carney Distinguished Service Award

Register Today for the Virtual Human Teratogens Course, November 2-4, 2021